Clinical Trial Update: Esophageal pH-MII Duration: 12 or 24 Hours?

View source ↗

Summary

A clinical trial comparing 12-hour versus 24-hour esophageal pH-impedance monitoring for gastroesophageal reflux disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Gastro Esophageal Reflux | Status: COMPLETED